260 related articles for article (PubMed ID: 29924315)
1. Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways.
Gonzalez-Gil A; Porell RN; Fernandes SM; Wei Y; Yu H; Carroll DJ; McBride R; Paulson JC; Tiemeyer M; Aoki K; Bochner BS; Schnaar RL
Glycobiology; 2018 Oct; 28(10):786-801. PubMed ID: 29924315
[TBL] [Abstract][Full Text] [Related]
2. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
3. Isolation, identification, and characterization of the human airway ligand for the eosinophil and mast cell immunoinhibitory receptor Siglec-8.
Gonzalez-Gil A; Li TA; Porell RN; Fernandes SM; Tarbox HE; Lee HS; Aoki K; Tiemeyer M; Kim J; Schnaar RL
J Allergy Clin Immunol; 2021 Apr; 147(4):1442-1452. PubMed ID: 32791164
[TBL] [Abstract][Full Text] [Related]
4. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
5. Induction of the endogenous sialoglycan ligand for eosinophil death receptor Siglec-8 in chronic rhinosinusitis with hyperplastic nasal polyposis.
Lee HS; Gonzalez-Gil A; Drake V; Li TA; Schnaar RL; Kim J
Glycobiology; 2021 Sep; 31(8):1026-1036. PubMed ID: 33755113
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.
Hudson SA; Bovin NV; Schnaar RL; Crocker PR; Bochner BS
J Pharmacol Exp Ther; 2009 Aug; 330(2):608-12. PubMed ID: 19458105
[TBL] [Abstract][Full Text] [Related]
7. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
Tateno H; Crocker PR; Paulson JC
Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
[TBL] [Abstract][Full Text] [Related]
8. Glycan array screening reveals a candidate ligand for Siglec-8.
Bochner BS; Alvarez RA; Mehta P; Bovin NV; Blixt O; White JR; Schnaar RL
J Biol Chem; 2005 Feb; 280(6):4307-12. PubMed ID: 15563466
[TBL] [Abstract][Full Text] [Related]
9. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.
Kiwamoto T; Katoh T; Evans CM; Janssen WJ; Brummet ME; Hudson SA; Zhu Z; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2015 May; 135(5):1329-1340.e9. PubMed ID: 25497369
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8.
Pröpster JM; Yang F; Rabbani S; Ernst B; Allain FH; Schubert M
Proc Natl Acad Sci U S A; 2016 Jul; 113(29):E4170-9. PubMed ID: 27357658
[TBL] [Abstract][Full Text] [Related]
12. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.
Nycholat CM; Duan S; Knuplez E; Worth C; Elich M; Yao A; O'Sullivan J; McBride R; Wei Y; Fernandes SM; Zhu Z; Schnaar RL; Bochner BS; Paulson JC
J Am Chem Soc; 2019 Sep; 141(36):14032-14037. PubMed ID: 31460762
[TBL] [Abstract][Full Text] [Related]
13. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
14. A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewis
Kroezen BS; Conti G; Girardi B; Cramer J; Jiang X; Rabbani S; Müller J; Kokot M; Luisoni E; Ricklin D; Schwardt O; Ernst B
ChemMedChem; 2020 Sep; 15(18):1706-1719. PubMed ID: 32744401
[TBL] [Abstract][Full Text] [Related]
15. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
[TBL] [Abstract][Full Text] [Related]
17. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
[TBL] [Abstract][Full Text] [Related]
18. Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death
Carroll DJ; Cao Y; Bochner BS; O'Sullivan JA
Front Immunol; 2021; 12():737988. PubMed ID: 34721399
[TBL] [Abstract][Full Text] [Related]
19. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
20. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
